Drugs / Monovalent Influenza Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03158038 | May → Dec 2017 | influenza | MedImmune LLC | Completed | Missed primary |
| Phase 4 | NCT02743117 | May → Nov 2016 | influenza | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03158038 ↗ |
| Modality | Vaccine | “new influenza virus vaccine strain” NCT02743117 ↗ |
| Route | Intranasal | “administered as intranasal spray” NCT02743117 ↗ |